Annual Brian Ott Research Symposium
Presented December 3, 2020
Session Overview
This session addresses scientific and ethical implications of recruitment success in Alzheimer’s disease clinical trials and explores predictors of drop out and retention.
Learning Objectives
After completing this webinar, participants will be able to:
- Distinguish the effects of currently available therapies from those in development.
- Name the main barriers to efficient accrual in Alzheimer’s disease clinical trials and describe the need for an evidence base of recruitment science in Alzheimer’s disease clinical trials.
- Recognize the scientific and ethical implications of recruitment success in Alzheimer’s disease clinical trials.
Presenter
- Joshua D. Grill, PhD; Wake Forest University School of Medicine, Neuroscience
Participate Now!